Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Assess the Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and Opioid-Induced Constipation

NCT02839889 is registered in ClinicalTrials.gov with Hospice of Henderson County, Inc. as lead sponsor.

NCT NCT02839889
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02839889 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Assess the Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and Opioid-Induced Constipation
Lead sponsor
Hospice of Henderson County, Inc.
Phase
Phase 4
Overall status
Terminated
Start date
September 30, 2016
Completion date
January 11, 2018
Enrollment
12 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, constipation, pain